Skip to main content
. 2009 Sep 28;15(36):4561–4565. doi: 10.3748/wjg.15.4561

Table 3.

COX-2 haplotypes in patients with CRC and controls

Haplotype Patients with CRC (n = 326) Controls (n = 369) OR (95% CI)
AC/AC 9 (2.8%) 8 (2.2%) 1.16 (0.40-3.42)
AG/AC 59 (18.1%) 74 (20.1%) 0.83 (0.54-1.27)
AG/AG 145 (44.5%) 150 (40.7%) Reference
GC/AC 1 (0.3%) - -
GG/AC 16 (4.9%) 38 (10.3%) 0.44 (0.22-0.85)
GG/AG 84 (25.8%) 86 (23.3%) 1.01 (0.68-1.50)
GG/GG 12 (3.7%) 13 (3.5%) 0.92 (0.38-2.24)